%1$s

Dr. Deleep Kumar Gudipudi Sr. Consultant-Radiation Oncologist & Clinical Director-Academics (Radiation Oncology)

Dr. Deleep Kumar Gudipudi

Dr. Deleep Kumar Gudipudi

MBBS, DNB, IGCS Physician Scholar Fellowship

Department: Radiation Oncology
Designation: Sr. Consultant-Radiation Oncologist & Clinical Director-Academics (Radiation Oncology)
Years Of Experience: 15
Location: Hitec City
Languages: English, Telugu, Hindi
Med Reg No: APMC 52964 & ECFMG 0-683-765-2 (USA)
Book An Appointment

Dr. Deleep Kumar Gudipudi is a Consultant Radiation Oncologist who specialises in the treatment of Head & Neck, Gastrointestinal and Genitourinary Malignancies. His other interests include Stereotactic Radiosurgery (SRS), Stereotactic Body Radiotherapy (SBRT), and Adaptive Radiotherapy.

After completing his medical training in Radiation Oncology at Basavatarakam Indo American Cancer Hospital and Research Institute, he undertook fellowship training at the world-renowned Simon Cancer Center and Proton Therapy Center, Radiation Oncology, Indiana University School of Medicine, Indianapolis, USA, under the supervision of Professor Dr. Giuseppe Del Priore (mentor), Professor Dr. Higinia Cardenes, and Professor Peter Johnston (Chairman Radiation Oncology).

Dr. Deleep Kumar has a prolific research record with 58 peer-reviewed publications, including oral and poster presentations at national and international meetings, and has authored a textbook chapter titled, “Impact of Chemotherapy and Radiotherapy on the Uterus in Fertility Preservation: Emerging Technologies and Clinical Applications.” Apart from peer-reviewed publications, he was a recipient of the Young Doctor Summit Fellow Award at the International Gynecological Cancer Society (IGCS) 14th Biennial Meeting, 2012, held at Vancouver, Canada, and an IGCS Traveling Scholars Program 2013 Grant to attend Simon Cancer Center, Indiana University School of Medicine, Indianapolis. He attended an advanced radiation oncology training course in IMRT/IGRT/SBRT at the National Cancer Institute Singapore in 2017.

After working for various renowned organisations for over a decade, he joined Yashoda Hospitals, Hitec City, as a Senior Consultant, Department of Radiation Oncology, to work with MR-LINAC (an advanced radiation machine with cutting-edge technology that enables daily adaptive treatments with the assistance of daily MRI scans).

Education Qualifications

Education Qualifications

  • Nov 2017-Nov 2017: IMRT/IGRT/SBRT Training at the National Cancer Institute Singapore, Singapore
  • Jan 2013-April 2013: IGCS Physician Scholar Fellowship, Simon Cancer Center and Proton Therapy Center, Radiation Oncology, Indiana University School of Medicine, Indianapolis and Bloomington, IN, USA
  • Feb 2009-Feb 2012: DNB Radiation Oncology, Indo-American Cancer Institute and Research Centre, Banjara Hills, Hyderabad (National Board of Examinations (NBE), New Delhi)
  • Jan 1999-May 2005: MBBS, Osmania Medical College, Koti, Hyderabad
ExperienceExperience
  • June 2023-Present: Senior Consultant Radiation Oncologist, Yashoda Hospitals, Hitec City, Hyderabad
  • Aug 2014-June 2023: Consultant Radiation Oncologist, Basavatarakam Indo-American Cancer Hospital and Research Institute, Banjara Hills, Hyderabad
  • Jan 2013-April 2013: IGCS Physician Scholar Fellow, Simon Cancer Center and Proton Therapy Center, Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN & Bloomington, IN, USA
  • Feb 2012-July 2014: Senior Registrar, Basavatarakam Indo-American Cancer Hospital and Research Institute, Banjara Hills, Hyderabad
  • Feb 2009-Feb 2012: DNB Resident, Indo-American Cancer Institute and Research Center, Banjara Hills, Hyderabad
  • Jan 2007-Jan 2008: Intern/Observer, Department of Gynecologic Oncology and Internal Medicine, New York Downtown Hospital, New York Presbyterian Healthcare, New York
  • July 2006-Aug 2006: Resident Medical Officer, North Point Hospitals, New Delhi, India
  • Research Experience:
  • Oct 2008-Present: Junior Editor (Technical Support), Journal of Atrial Fibrillation, Overland Park, Kansas
  • Jan 2007-Jan 2009: Research Associate, New York Downtown Hospital, New York Presbyterian Healthcare, New York
  • Certifications:
  • Sep-Oct 2009: Certificate in Pain and Palliative Care Medicine, American Cancer Society (ACS), International Network for Cancer Treatment and Research (INCTR), Pallium India, MNJ Institute of Oncology and Regional Cancer Center, Hyderabad, India
  • May 2007: CITI Refresher Course-Human Research Curriculum, Weill College of Medicine, Cornell University, NY, New York, USA
  • Jan 2007: Certificate Course in Human Subjects
  • Jan 2007: Certificate Course in HIPPA Training, New York University - School of Medicine (Institutional Review Board of Research Associates) NY, New York, USA
Services offeredServices offered
  • Radiotherapy on MR Linac & CT Linac
  • MRI Guided Adaptive Radiotherapy (MRgRT-MR Linac)
  • Complex Radiation Techniques (IMRT, VMAT-RapidArc, IGRT, SRS, SBRT, Brachytherapy)
Special Interest and ExpertiseSpecial Interest and Expertise
  • MRI Guided Adaptive Radiotherapy and Stereotactic MRI Guided Adaptive Radiotherapy (SMART) (Breast, Prostate, Brain, Lung, Liver, Prostate and Spine)
  • Stereotactic Body Radiotherapy (SBRT) – Lung, Liver, Prostate and Spine
  • Stereotactic Radiosurgery (SRS) – Brain (Benign & Malignant)
  • Total Body Irradiation (TBI)
  • Genitourinary Malignancies
  • Brain Tumors
  • Head & Neck Malignancies
  • Gynecological Malignancies
  • Gastrointestinal Malignancies
Professional MembershipProfessional Membership
  • Life Member, Association of Radiation Oncologists of India (AROI)
  • Life Member, Indian Medical Association (IMA)
Research & PublicationsResearch & Publications
  • A.G. Gopal, Deleep Kumar Gudipudi, H. Kauser, R. Nabariya, G. P, Vineeth Kumar. S, S. Gunda, K.R. Alluri, V.C. Patil, Pavan Kumar B, N.V.N.M.Stesty. Total body irradiation (TBI) by helical Tomotherapy- single institution experience from India. Radiotherapy & Oncology (PO-1168- S934) Volume 182 Supplement 1(2023) ESTRO 2023.
  • S. Vineeth Kumar, Deleep Kumar Gudipudi, Ashwini Gopal, Madhusudhana Sresty, Pavan Kumar Boyella, Veerendra Patil. A single institute prospective observational study on the dosimetric and clinical outcomes of using total body irradiation in tomotherapy as conditioning regimen before stem cell transplant in leukemia patients. J Can Res Ther - 18 - Supplement Issue 1(S122) – 2022.
  • Renu S. Nabariya, Deleep Kumar Gudipudi, Ashwini Gopal, Madhusudhana Sresty, Veerendra Patil, Pavan Kumar Boyella. Total body irradiation using helical tomotherapy as a part of conditioning regimen for stem cell transplantation in patients of aplastic anemia and lymphoma – Tertiary cancer center experience. J Can Res Ther - 18 - Supplement Issue 1 (S116)- 2022 (Abstract: 317)
  • M. Sudharshan Gupta, Hiren Poojara, Deleep Kumar Gudipudi. Hypofractionated (43.5Gy/15#) postmastectomy radiotherapy for patients with high-risk breast cancer: A new alternative, prospective study J Can Res Ther, 18 - Supplement Issue 1(S32) – 2022 (Abstract: 090)
  • Kumar Selvaraj Vinodh, Gudipudi Deleep, Khera Rachna, Murthy Sudha Primary intracranial extra-skeletal myxoid chondrosarcoma of right lateral ventricle with EWSR1 gene fusion: a case report and review of literature. ecancer (2021) 15 1257
  • Sresty NVNM, Gudipudi Deleep, Krishnam Raju A, Anil Kumar T, Lakshmi VRP, Srikanth G, Narasimha M. Total body irradiation of bone marrow transplant using helical TomoTherapy with a focus on the quality of dose contribution at junction target volumes. Strahlenther Onkol. 2021, 197(8):722-729. doi: 10.1007/s00066-021-01769-2. Epub ahead of print. PMID: 33852037.
  • Rao T S, Raju KVVN, Patnaik SC, Reddy P, Saksena AR, Rajappa S, Mallavarapu KM, Santa A, Gudipudi Deleep, Boleneni N, Usofi Z, Gujjuru S, Smith L, Are C, Nusrath S. Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in India. J Surg Oncol. 2021 Mar 2. doi: 10.1002/jso.26444. Epub ahead of print. PMID: 33650697.
  • Selvaraj VK, Gudipudi Deleep. Impact of Coronavirus-2019 (COVID-19) Pandemic on Work Routine, Practice and Mental State of Radiation Oncologists in India: An online survey. ecancer 2021, 15:1165. https://doi.org/10.3332/ecancer.2021.1165
  • Selvaraj VK, Gudipudi Deleep. Fundamentals to clinical application of nanoparticles in cancer immunotherapy and radiotherapy. ecancer 2020, 14:1095.
  • Selvaraj VK, Gudipudi DK. Primary cerebral neuroblastoma in young adult - Int J Neurooncol 2020;3:101-3. https://doi.org/10.4103/IJNO.IJNO_19_20
  • Selvaraj VK, Gudipudi DK. Surge in pelvic and para-aortic nodal involvement in newly diagnosed cervical cancer patients during coronavirus disease 2019: A chance or imminent reality? - Cancer Res Stat Treat 2020;3:829-30.
  • Selvaraj VK, Gudipudi DK. Recurrent and Hodgkin’s lymphoma-associated multicentric Castleman’s disease in head and neck region. Int J Otorhinolaryngol Head Neck Surg 2020;6:1882-5. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20204193
  • Selvaraj VK, Gudipudi DK. Skin metastasis within radiation field in treated squamous cell carcinoma of larynx. Int J Otorhino laryngol Head Neck Surg 2020;6:1886-90. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20204194
  • Selvaraj VK, Gudipudi DK. Cost analysis and overview of single versus multiple fraction palliative radiotherapy for painful bone metastasis, Annals of Oncology, Volume 30, Supplement-9, November 2019
  • Selvaraj VK, Gudipudi DK. Stereotactic body radiation therapy for non small cell lung cancer: An analysis on fractionation schedules, dosimetric parameters and clinical outcomes. Thorax and Abdomen. J Can Res Ther 2019;15, Suppl S2:275-76.
  • Selvaraj VK, Raju AK, Gudipudi DK. Sinonasal tract malignancies - Frontiers Unconquered. Dr.MC Pant and Dr MS Gujral. J Can Res Ther 2019;15, Suppl S2:305. https://www.cancerjournal.net/text.asp?2019/15/9/303/271706 - Abstract (Best Paper)
  • Selvaraj VK, Gudipudi DK. Intracranial extra-skeletal myxoid chondrosarcoma with EWSR1 gene fusion. CNS. J Can Res Ther 2019;15, Suppl S2:196-197.
  • Madhusudhana Sresty NVN, Raju AK, Reddy BN, Sahithya VC, Mohmd Y, Kumar GD, Kumar TA, Rushdi T, Aparna S, Prasad GD, Bajwa HK. Evaluation and Validation of IBA I'MatriXX Array for Patient-Specific Quality Assurance of TomoTherapy®. J Med Phys. 2019, 44(3):222-227.
  • Selvaraj V, Gudipudi DK et al. Clinical outcomes and fractionation schedules in vestibular schwanommas. Poster Presentation in International congress on Radiation Research - ICRR 2019
  • Selvaraj V, Gudipudi DK et al. SBRT in NSCLC - An analysis of fractionation, radio biologic & dosimetric parameters. Poster presentation in International congress on Radiation Research -ICRR 2019
  • Selvaraj V, Gudipudi DK et al. Clinical profile and dosimetric analysis of stereotactic fractionated schedules in vestibular schwanommas. Poster Presentation at Apollo Cancer Conclave 2019
  • Ashwini G, G Rajeev, Gudipudi DK. Bone metastasis – a retrospective analysis of fractionation schedules, and re-irradiation in a tertiary cancer centre. International Journal of Contemporary Medical Research 2018; 5(2):B1-B3.
  • Gopal A, Gudipudi DK. A case of Squamous cell carcinoma of oral cavity treated with radical radiation in a patient with Fanconi anemia. J Case Rep Images Oncology 2017; 3:69–72.
  • Nellore L, Gudipudi DK et al. Role of Neoadjuvant Chemo radiotherapy in locally advanced esophageal or oesophagogastric junction cancers - A single institute analysis with pathological complete response rates. Standee Poster Presentation at 2nd Indian Cancer Congress 2017
  • Guntupalli R, Gudipudi DK et al. Comparison of palliative radiation – single fraction vs. multiple fractions in bone metastasis: Single Institution Retrospective analysis. Standee Poster Presentation at 2nd Indian Cancer Congress 2017
  • Kulkarni BSN, Bajwa H, Mukka C, Sharma SD, Singareddy R, Gudipudi DK, Alluri KR et al. CT- and MRI-based gross target volume comparison in vestibular Schwanomma. Reports of Pract Oncol & Radiotherapy 2017, 22: 201–208.
  • Kumari S, Gondi J, Nemade H, Rao LMCS, Gudipudi DK, Rao TS. Hypothyroidism in Carcinoma of the Tongue with Adjuvant Treatment. Rambam Maimonides Med J 2017; March 29. doi:10.5041/RMMJ.10290 [ePub ahead of print]
  • Ahamed S, Singh N, Gudipudi DK, Mulinti S, Talluri A, Bhudevi Soubhagya B, Sresty M. Assessment of monitor unit limiting strategy using volumetric modulated arc therapy for cancer of hypopharynx. Physica Medica 2017; 35:73–80.
  • Ashwini G, Kauser H, Gudipudi DK, Chandipriya V, Alluri KR et al. Comparison between static and dynamic intensity modulated radiosurgery planning: Single institution retrospective analysis. Medical Physics. J Can Res Ther 2016;12:71-7
  • Kauser H, Gudipudi DK, Chandipriya V, Alluri KR, Ashwini G. Retrospective study to compare volumetric dose in simultaneous integrated boost versus sequential boost in head and neck cancers. Head and Neck. J Can Res Ther 2016;12: 44-65
  • Abdullah AW, Kauser H, Gudipudi DK, Chandipriya V, Alluri KR, Ashwini G et al. Survival and patterns of failure in oral cancers: Single institution retrospective study. Head and Neck. J Can Res Ther 2016; 12: 44-65.
  • Talluri AK, Yarrama AR, Ahamed S, Gudipudi DK et al. Dose variation due to change in planned position for patients with carcinoma of the cervix undergoing high-dose-rate brachytherapy- 2D dose analysis. Int J Cancer Ther Oncol 2015; 3(1):030121.
  • Del Priore G, Gudipudi DK. Promise of uterine transplant - Myth or a reality. Maturitas. 2014; 77(1): 20-3.
  • Talluri AK, Alluri KR, Gudipudi DK, Ahamed S et al. Study of positional dependence of dose to bladder, pelvic wall and rectal points in High-Dose-Rate Brachytherapy in cervical cancer patients. J Med Phys 2013; 38:178-84.
  • Gudipudi DK, Alluri KR, De Leon MB, Cardenes HR, Del Priore G. Comparing intensity modulated radiotherapy and conventional external beam radiotherapy in cervical cancer. J Clin Oncol 31, 2013 (suppl; abstr 5610 – ASCO meeting)
  • De Leon MB, Del Priore G, Gudipudi DK. Synchronous primary ovarian and endometrial cancer in recent years: Changes in recent years. J Clin Oncol 31, 2013 (suppl; abstr e16554 – ASCO Meeting)
  • Gudipudi DK, Alluri KR, De Leon MB, Cardenes HR, Del Priore G (2013, May-June). Comparing intensity modulated radiotherapy and conventional external beam radiotherapy in cervical cancer. ASCO 2013 Annual Meeting, Chicago, IL
  • Seli E, Agarwal A, Fertility Preservation: Emerging Technologies and Clinical Applications, ISBN-10: 1441917829 | ISBN-13: 978-1441917829, Springer 2012 (Chapter 5: Impact of chemotherapy and radiotherapy on Uterus. Fields AL, Gudipudi DK, Del Priore G)
  • Del Priore G, Gudipudi DK, Montemarano N, Restivo A, Stega J, Arslan A. Oral Diindolylmethane (DIM): Pilot evaluation of a nonsurgical treatment for cervical dysplasia. Gynecol Oncol 2010; 116: 464-467.
  • Del Priore G, Montemarano N, Gudipudi D, Nair A.R, Klapper A, Nagy S, Vaz C. Randomized clinical trial of oral Diindolylmethane: A nonsurgical treatment for cervical dysplasia. Gynecol Oncol 2009; 112: S 51
  • Sierecki A, Gudipudi DK, Montemarano N, Del Priore G. Comparison of Endometrial Aspiration Biopsy Techniques: Specimen Adequacy. J Reprod Med 2008; 53:760– 764.
  • Del Priore G, Gudipudi DK, Montemarano N, Hartzfeld K. Decreased breast cancer rates among women with primary placental site tumors. Obstet Gynecol. 2008 Apr; 111(4): 55S.
  • Del Priore G, Gudipudi DK, Nair AR, Montemarano N, Feret M, Stega J. Potential candidates for uterine transplantation: An assessment of need. Obstet Gynecol. 2008 Apr; 111(4): 16S.
  • Del Priore G, Gudipudi DK, Ungar L, Smith JR. Response to: "Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature". Gynecol Oncol. 2007 Jun; 105(3): 830-831.
  • Immunosuppression in allograft primate uterine transplantation. Fertil Steril. 2007 Sep; 88(1 Suppl): S223.
  • Gudipudi D, Montemarano N, Del Priore G. Alternative approaches to cervical stenosis. Fertil Steril. 2007 Sep; 88(3): 763-764.
  • Gudipudi DK, Hartzfeld K, Montemarano N, Del Priore G. Decreased breast cancer rates among women with choriocarcinoma. Gynecol Oncol. 2008 Aug; 110(2): 202-205. Cited in PubMed; PMID: 18514799.
  • Montemarano N, Del Priore G, Gudipudi D, Nair A, Arslan A. Oral diindolylmethane (DIM): a nonsurgical treatment for cervical dysplasia. Fertil Steril. 2007 Sep; 88(1 Suppl): S16-S17.
  • Nair AR, Montemarano N, Gudipudi D, Stega J, Smith JR, Del Priore G. Potential candidates for uterine transplantation: An assessment of need. Fertil Steril. 2007 Sep; 88(1 Suppl): S224-225.
  • Tsirkin S, Gudipudi D, Wong R, Montemarano N, Del Priore G, Grinfeld E. Physician and nurse accuracy of estimating blood loss. Fertil Steril. 2007 Sep; 88(1 Suppl): S222.
  • Gudipudi D, Montemarano N, Arslan A. Del Priore G (2009, November). Oral diindolylmethane (DIM): Pilot evaluation of a nonsurgical treatment for cervical dysplasia. Poster to be presented at Association of Radiation Oncologists of India (AROI), Hyderabad, India
  • Del Priore G, Montemarano N, Gudipudi D, Nair A.R, Klapper A, Nagy S, Vaz C, Arslan A. (2009 February) Randomized clinical trial of oral Diindolylmethane: A nonsurgical treatment for cervical dysplasia. Poster Presented at Society of Gynecologic Oncologists (SGO); San Antonio, TX
  • Del Priore G, Gudipudi DK, DO, Montemarano N, Hartzfeld K. (2008, May). Decreased breast cancer rates among women with primary placental site tumors. Poster presented at American College of Obstetricians and Gynecologists (ACOG); New Orleans, LA
  • Del Priore G, Gudipudi DK, Nair AR, Montemarano N, Feret M, Stega J. (2008, May). Potential candidates for uterine transplantation: An assessment of need. Poster presented at American College of Obstetricians and Gynecologists (ACOG); New Orleans, LA
  • Gudipudi D, Del Priore G, Schlatt S, Montemarano N, Stega J. (2007, October). Immunosuppression in allograft primate uterine transplantation. Poster presented at American Society for Reproductive Medicine (ASRM); Washington, DC
  • Nair AR, Montemarano N, Gudipudi D, Stega J, Smith JR, Del Priore G. (2007, October). Potential candidates for uterine transplantation an assessment of need. Poster presented at American Society for Reproductive Medicine (ASRM); Washington, DC
  • Tsirkin S, Gudipudi D, Wong R, Montemarano N, Del Priore G, Grinfeld E. (2007, October). Physician and nurse accuracy of estimating blood loss. Poster presented at American Society for Reproductive Medicine (ASRM); Washington, DC
  • Montemarano N, Del Priore G, Gudipudi D, Nair A, Arslan A. (2007, October). Oral diindolylmethane (DIM): a nonsurgical treatment for cervical dysplasia. Oral Presentation presented at American Society for Reproductive Medicine (ASRM), Washington, DC.
Awards and AchievementsAwards and Achievements
  • Jan 2013: ‘IGCS Traveling Scholarship’, Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA. IGCS Traveling Scholars Program (Grant to attend Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA)
  • Oct 2012: ‘Young Doctors Summit Fellowship’ at International Gynecological Cancer Society (IGCS) 14th Biennial Meeting, October 13-16, 2012, Vancouver, Canada. YDS Fellow Travel Grant to attend 14th Biennial Meeting, Vancouver, BC, Canada.
  • May 2008: 'Blue Ribbon Designation' for poster presentation, “Decreased breast cancer rates among women with primary placental site tumors,” at The American College of Obstetrics and Gynecology (ACOG) 56th Annual Clinical Meeting
  • Oct 2007: Society of Reproductive Surgeons ‘SRS In-Training Awards for Research’ for abstracts, “Physician and nurse accuracy of estimating blood loss, P-345”, “Potential candidates for uterine transplantation: An assessment of need, P-354”, at The American Society for Reproductive Medicine (ASRM) 63rd Annual Meeting
Research Grants & ProjectsFAQ'S
  1. 1. Why do patients frequently visit Dr. Deleep Kumar Gudipudi?

    Patients visit Dr. Deleep Kumar Gudipudi to receive treatment for various cancers.

  2. 2. What is Dr. Deleep Kumar Gudipudi's educational qualification?

    Dr. Deleep Kumar Gudipudi holds the following qualifications: MBBS, DNB, IGCS Physician Scholar Fellowship.

  3. 3. What does Dr. Deleep Kumar Gudipudi specialise in?

    Dr. Deleep Kumar Gudipudi is a Sr. Consultant-Radiation Oncologist & Clinical Director-Academics (Radiation Oncology) who specialises in Hypofractionation (Stereotactic Body Radiotherapy (SBRT) – Lung, Liver, Spine), Stereotactic Radiosurgery (SRS) – Brain (Benign & Malignant), Adaptive Radiotherapy, and the treatment and management of Genitourinary Malignancies, Head & Neck Malignancies, Gynecological Malignancies, and Gastrointestinal Malignancies, among others.

  4. 4. Where does Dr. Deleep Kumar Gudipudi practice?

    Dr. Deleep Kumar Gudipudi practices at Yashoda Hospitals, Hitec City.

  5. 5. How can I book Dr. Deleep Kumar Gudipudi’s appointment?

    You can schedule an appointment with Dr. Deleep Kumar Gudipudi for both an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.

Blogs by Dr. Deleep Kumar Gudipudi

MR Linac: A Beacon of Hope for Cancer Patients

MR Linac: A Beacon of Hope for Cancer Patients

Oct 27, 2023 18:27

In the world of modern medicine, technological advancements continue to push the boundaries of what is possible.

Read More..

X
Select Department
Not Sure of the Specialty?
X

Choose your date & Slot

Change Date
Monday, OCTOBER 30
Enter Patient Details

Please Note: This session ends in 3:00 mins

Not Finding Your Preferred Slots?